Precision BioSciences (DTIL)

Precision BioSciences (DTIL) Financial Statements


Precision BioSciences Financial Overview

Precision BioSciences's market cap is currently ―. The company's EPS TTM is $-1.391; its P/E ratio is -0.61; Precision BioSciences is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 10.60M$ 7.36M$ 3.82M$ 3.32M$ 6.34M
Gross Profit-----
EBIT$ -28.00M$ -23.54M$ -30.86M$ -28.13M$ -22.24M
EBITDA$ -25.73M$ -21.29M$ -28.63M$ -25.87M$ -19.74M
Net Income Common Stockholders$ -28.49M$ -23.95M$ -31.04M$ -28.17M$ -22.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 189.58M$ 212.05M$ 184.13M$ 116.22M$ 143.66M
Total Assets$ 238.17M$ 271.73M$ 297.16M$ 181.35M$ 211.50M
Total Debt$ 27.04M$ 27.46M$ 27.87M$ 8.68M$ 9.11M
Net Debt$ -162.54M$ -184.59M$ -156.27M$ -107.54M$ -134.55M
Total Liabilities$ 177.74M$ 187.35M$ 194.14M$ 111.69M$ 120.33M
Stockholders Equity$ 60.43M$ 84.38M$ 103.02M$ 69.66M$ 91.17M
Cash Flow-
Free Cash Flow$ -22.48M$ 28.10M$ -25.00M$ -29.69M$ -25.19M
Operating Cash Flow$ -21.84M$ 29.19M$ -24.22M$ -28.87M$ -23.68M
Investing Cash Flow$ -632.00K$ -1.09M$ -779.00K$ -818.00K$ -1.50M
Financing Cash Flow$ 0.00$ -180.00K$ 92.92M$ 2.25M$ 8.38M
Currency in USD

Precision BioSciences Earnings and Revenue History

Precision BioSciences Debt to Assets

Precision BioSciences Cash Flow

Precision BioSciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis